These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 7744879)
21. Age related changes in the lipoprotein substrates for the esterification of plasma cholesterol in rats. Lee SM; Kudchodkar BJ; Lacko AG Mech Ageing Dev; 1991 Nov; 61(1):85-98. PubMed ID: 1779703 [TBL] [Abstract][Full Text] [Related]
23. ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity. Amaya-Montoya M; Pinzón-Cortés JA; Silva-Bermúdez LS; Ruiz-Manco D; Pérez-Matos MC; Jiménez-Mora MA; Mendivil CO Lipids Health Dis; 2020 May; 19(1):106. PubMed ID: 32450892 [TBL] [Abstract][Full Text] [Related]
24. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes. Fournier N; Atger V; Paul JP; de la Llera Moya M; Rothblat G; Moatti N Atherosclerosis; 1999 Dec; 147(2):227-35. PubMed ID: 10559507 [TBL] [Abstract][Full Text] [Related]
26. Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins. Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP Atherosclerosis; 2000 Dec; 153(2):491-8. PubMed ID: 11164439 [TBL] [Abstract][Full Text] [Related]
27. Effect of lecithin:cholesterol acyltransferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma. Bisgaier CL; Sachdev OP; Lee ES; Williams KJ; Blum CB; Glickman RM J Lipid Res; 1987 Jun; 28(6):693-703. PubMed ID: 3611972 [TBL] [Abstract][Full Text] [Related]
28. Lecithin-cholesterol acyltransferase (LCAT) catalyzes transacylation of intact cholesteryl esters. Evidence for the partial reversal of the forward LCAT reaction. Sorci-Thomas M; Babiak J; Rudel LL J Biol Chem; 1990 Feb; 265(5):2665-70. PubMed ID: 2406238 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner. Brousseau ME; Santamarina-Fojo S; Vaisman BL; Applebaum-Bowden D; Bérard AM; Talley GD; Brewer HB; Hoeg JM J Lipid Res; 1997 Dec; 38(12):2537-47. PubMed ID: 9458277 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of human lecithin:cholesterol acyltransferase in mice offers no protection against diet-induced atherosclerosis. Mehlum A; Gjernes E; Solberg LA; Hagve TA; Prydz H APMIS; 2000 May; 108(5):336-42. PubMed ID: 10937770 [TBL] [Abstract][Full Text] [Related]
32. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT. Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726 [TBL] [Abstract][Full Text] [Related]
34. Cholesteryl ester transfer protein expressed in lecithin cholesterol acyltransferase-deficient mice. Wu CA; Tsujita M; Okumura-Noji K; Usui S; Kakuuchi H; Okazaki M; Yokoyama S Arterioscler Thromb Vasc Biol; 2002 Aug; 22(8):1347-53. PubMed ID: 12171799 [TBL] [Abstract][Full Text] [Related]
35. High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice. Bielicki JK; Forte TM; McCall MR; Stoltzfus LJ; Chiesa G; Sirtori CR; Franceschini G; Rubin EM J Lipid Res; 1997 Nov; 38(11):2314-21. PubMed ID: 9392429 [TBL] [Abstract][Full Text] [Related]
36. Lecithin-cholesterol acyltransferase and the lipoprotein abnormalities of parenchymal liver disease. Day RC; Harry DS; Owen JS; Foo AY; McIntyre N Clin Sci (Lond); 1979 Jan; 56(6):575-83. PubMed ID: 225095 [TBL] [Abstract][Full Text] [Related]
37. Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency. Nanjee MN; Cooke CJ; Olszewski WL; Miller NE J Lipid Res; 2000 Aug; 41(8):1317-27. PubMed ID: 10946020 [TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins. Zhao Y; Thorngate FE; Weisgraber KH; Williams DL; Parks JS Biochemistry; 2005 Jan; 44(3):1013-25. PubMed ID: 15654758 [TBL] [Abstract][Full Text] [Related]
39. Evidence for the presence in human plasma of lecithin: cholesterol acyltransferase activity (beta-LCAT) specifically esterifying free cholesterol of combined pre-beta- and beta-lipoproteins. Studies of fish eye disease patients and control subjects. Carlson LA; Holmquist L Acta Med Scand; 1985; 218(2):197-205. PubMed ID: 4061123 [TBL] [Abstract][Full Text] [Related]
40. Mice overexpressing human lecithin: cholesterol acyltransferase are not protected against diet-induced atherosclerosis. Mehlum A; Muri M; Hagve TA; Solberg LA; Prydz H APMIS; 1997 Nov; 105(11):861-8. PubMed ID: 9393557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]